INDOUS · Indo Us Biotech Ltd · Biotechnology & Drugs
INDOUS · Indo Us Biotech Ltd · Biotechnology & Drugs
As of 05 Nov close
52-week range
58.1% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹33 Cr
Revenue YoY
PAT YoY
-35.3%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
1.7
P/S (TTM)
1.4
Sector P/E
21.7
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| INDOUS (this stock) | 15.4 | 1.7 | +10.2% | +12.4% | 0.4 | 0.0% |
| Sun Pharmaceutical Industries | 38.4 | 5.6 | +19.1% | +14.2% | 0.47 | +0.8% |
| Divi's Laboratories | 59.7 | 14.5 | +26.1% | +17.4% | 0 | +0.3% |
| Torrent Pharmaceuticals | 72.7 | 19.2 | +15.3% | +27.1% | 141.16 | +0.8% |
Promoter
stable
FII
falling 1q
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedThe report outlines Indo Us Bio-Tech Limited's corporate governance structure, including the appointment of new directors and auditors. It mentions the company's focus on research and development, quality commitment, and a farmer-centric approach. The document also highlights the company's integrated seed business model, marketing and distribution network, infrastructure, and technology. The report includes sections on corporate social responsibility and compliance with governance standards.
- Appointment of new independent directors and auditors as part of corporate governance updates.
- Emphasis on research and development as the foundation of innovation.
- Integrated seed business model with a focus on quality and farmer-centric strategies.
- Development of marketing and distribution networks alongside infrastructure and technology capabilities.
- Inclusion of corporate social responsibility activities and compliance with governance regulations.
Key takeaway: The company is strengthening its corporate governance framework while maintaining a focus on innovation and farmer-centric strategies.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNo governance disclosures identified in INDOUS's filed documents yet.